Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

79.96
-4.6300-5.47%
Volume:1.41M
Turnover:113.34M
Market Cap:2.81B
PE:-1.56
High:82.22
Open:82.22
Low:78.71
Close:84.59
Loading ...

Is Avis Budget Group Inc. (NASDAQ:CAR) a Cheap Hot Stock to Buy Right Now?

Insider Monkey
·
18 Apr

KIA AMERICA'S GROUNDBREAKING CAR CONFIGURATOR ON TIKTOK NAMED "BEST SOCIAL CAMPAIGN" BY MEDIAPOST

PR Newswire
·
18 Apr

Hertz's stock was flat this year. Billionaire Bill Ackman is driving it higher for the second straight day.

Dow Jones
·
17 Apr

3 Reasons CAR is Risky and 1 Stock to Buy Instead

StockStory
·
17 Apr

Hertz's stock was flat this year. Now billionaire Bill Ackman is driving it higher.

Dow Jones
·
16 Apr

CAR Group's (ASX:CAR) five-year earnings growth trails the strong shareholder returns

Simply Wall St.
·
14 Apr

Avis Budget Group (CAR): Among the Top Stocks in Ken Griffin’s Portfolio to Buy According to Analysts

Insider Monkey
·
12 Apr

Higher Demand for Used Autos to Boost Rental Car Companies -- Market Talk

Dow Jones
·
11 Apr

Avis Budget Group, Hertz Global Holdings Could Benefit From US Tariffs, BofA Securities Says

MT Newswires Live
·
11 Apr

Ford, GM, Stellantis Face $41.9 Billion Higher Cost From Tariffs, CAR Report Says

MT Newswires Live
·
11 Apr

Bank of America Securities Keeps Their Buy Rating on Avis Budget (CAR)

TIPRANKS
·
11 Apr

Avalon GloboCare Secures Patent for CAR-T Technology

TIPRANKS
·
10 Apr

Avalon announces issuance of patent for CAR-T, CAR-NK cell technology in China

TIPRANKS
·
10 Apr

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

GlobeNewswire
·
10 Apr

CAR Bull Sees Demand Supporting Brazil Business -- Market Talk

Dow Jones
·
10 Apr

CAR Benefits From Demand in North America Despite Rising Fleet Costs

Zacks
·
08 Apr

Ground Transportation Stocks Q4 Results: Benchmarking Landstar (NASDAQ:LSTR)

StockStory
·
08 Apr

Allogene Therapeutics granted three Fast Track Designations for ALLO-329

TIPRANKS
·
07 Apr

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

GlobeNewswire
·
07 Apr

Battle of the online classifieds: Should I buy Car Group or Seek shares?

MotleyFool
·
07 Apr